PIPE complements your Technology Transfer Office — not replacing it, but extending its reach across the full portfolio of IP, so that more of your research creates measurable real-world impact.
If your team has been recommended for spin-out or licence at ICURe Exploit, PIPE is the next step. See exactly how the two programmes fit together.
Technology Transfer Offices are doing exceptional work — but they face a structural challenge: enormous portfolios, limited resource, and commercial pathways that require deep domain expertise, active operator engagement, and patient capital that the institution cannot provide alone.
The result is a long tail of promising innovations that never progress beyond early disclosure. Not because the science is weak — but because the translation infrastructure does not exist to move them forward systematically. PIPE is that infrastructure.
PIPE operates as an external ecosystem layer, complementing your TTO’s processes, respecting your governance, and protecting your IP, whilst dramatically expanding the volume and quality of opportunities that can progress.
Innovations are submitted without disclosing the inventive step. IP moves to a protected digital vault, allowing arm’s-length review whilst enabling both patenting and publishing to proceed on your timeline.
Every project receives an empirical commercial, environmental, and societal viability assessment — so your TTO can prioritise with confidence rather than gut instinct.
PIPE Associates — experienced commercial operators — are matched to validated projects, bringing deep domain expertise to build the commercial pathway alongside your researchers.
Projects that pass validation can access up to €2m in initial funding through the PIPE gDAO and PGF Launchpad — with no upper limit on subsequent rounds through PIPExchange.
PIPE provides structured, auditable documentation of translational activity — strengthening your REF impact case and stakeholder reporting with immutable progress records.
Unlike one-off advisory engagements, the PIPE QED system creates a standardised, repeatable process across all disciplines and faculties — building institutional capability over time.
PIPE is designed to be compatible with university IP protection requirements, publication timelines, and governance structures. Innovations are never publicly disclosed during the assessment process. The inventive step remains protected throughout, and no commercial engagement occurs without explicit institutional sign-off.
We begin with a confidential conversation to understand your portfolio, existing processes, and commercialisation objectives — and to confirm that PIPE is the right fit for your institution.
We agree the terms of collaboration — including IP ownership, revenue sharing, governance, and how PIPE integrates with your TTO processes — before any innovation is disclosed.
Researchers submit innovations through the PIPE platform. Each submission is assessed for commercial, environmental, and societal viability within a defined timeframe — producing a structured Go/No-Go report.
Validated innovations progress to formal evaluation — market analysis, use-case definition, competitive framing, and route-to-commercialisation planning — producing an investment-ready dossier.
PIPE Associates are matched to projects — bringing domain, technical, and commercial expertise to form the venture, structure IP, build the team, and prepare for capital deployment.
Validated, Associate-backed ventures access PIPE investor capital — with onward progression to PIPExchange listing and, ultimately, IPO. The institution retains agreed equity and licence value throughout.
Start a confidential conversation with the PIPE team to explore how we can complement your TTO and unlock more of your institution’s IP portfolio.